Hanifi ÜÇPUNAR, Hakan SOFU, Yalkın ÇAMURCU, Adem ÇÖBDEN, Serap BULUT ÇÖBDEN, Hüseyin DEMİREL, Ahmet SEVENCAN

Audiometric threshold shifts after total knee arthroplasty by using gentamicin-loaded bone cement

Background/aim: The aim of this study was to investigate postoperative audiometric threshold shifts in patients who underwentprimary total knee arthroplasty (TKA) using gentamicin-loaded bone cement (GLBC) in comparison with the ones who underwentTKA without GLBC.Materials and methods: Forty patients (gentamicin group) who underwent primary TKA using GLBC and 29 patients (control group)who underwent primary TKA using standard bone cement were included in this prospective case-control study. Baseline pure-toneaudiometric evaluation was performed preoperatively and repeated at the postoperative third day for all patients. Control audiometricevaluation was performed weekly for patients who were diagnosed with ototoxicity according to audiometric threshold shifts.Results: Ototoxicity was diagnosed in 8 of 40 patients (20%) in the gentamicin group according to postoperative audiometric thresholdshifts, whereas no ototoxicity was observed in the control group. Patients who were diagnosed with ototoxicity had no permanentaudiometric threshold shifts in follow-up audiometric evaluation and these patients had no clinical complaints of difference in hearing.Conclusion: According to our results, audiometric threshold shifts can be detected in patients who undergo primary TKA usinggentamicin loaded bone cement. However, no permanent shifts were observed during close follow-up.

PDF

___

1. Petursson G, Fenstad AM, Havelin LI, Gøthesen Ø, Lygre SH et al. Better survival of hybrid total knee arthroplasty compared to cemented arthroplasty. Acta Orthop 2015; 86 (6): 714-720. doi:10.3109/17453674.2015.1073539
2. Crook PD, Owen JR, Hess SR, Al-Humadi SM, Wayne JS, Jiranek WA. Initial stability of cemented vs cementless tibial components under cyclic load. J Arthroplasty 2017; 32 (8): 2556-2562. doi: 10.1016/j.arth.2017.03.039
3. Wang J, Zhu C, Cheng T, Peng X, Zhang W et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 2013; 8 (12): e82745.
4. Bohm E, Petrak M, Gascoyne T, Turgeon T. The effect of adding tobramycin to Simplex P cement on femoral stem micromotion as measured by radiostereometric analysis: a 2-year randomized controlled trial. Acta Orthop 2012; 83 (2): 115-120. doi:10.3109/17453674.2011.652885
5. Hanssen AD. Prophylactic use of antibiotic bone cement: an emerging standard--in opposition. J Arthroplasty 2004; 19 (4 Suppl. 1): 73-77.
6. Joseph TN, Chen AL, Di Cesare PE. Use of antibioticimpregnated cement in total joint arthroplasty. J Am Acad Orthop Surg 2003; 11 (1): 38-47.
7. Trippel SB. Antibiotic-impregnated cement in total joint arthroplasty. J Bone Joint Surg Am 1986; 68 (8): 1297-1302.
8. Overstreet D, McLaren A, Calara F, Vernon B, McLemore R. Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effective. Clin Orthop Relat Res 2015; 473 (1): 337-347.
9. Jung J, Schmid NV, Kelm J, Schmitt E, Anagnostakos K. Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci 2009; 6 (5): 265-273.
10. Van Raaij TM, Visser LE, Vulto AG, Verhaar JA. Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty 2002; 17 (7): 948-950.
11. De Klaver PA, Koning JD, Janssen RP, Derijks LJ. High systemic gentamicin levels and ototoxicity after implantation of gentamicin beads in a 70-year-old man--a case report. Acta Orthop 2009; 80 (6): 734-736.
12. Haydon RC, Blaha JD, Mancinelli C, Koike K. Audiometric thresholds in osteomyelitis patients treated with gentamicinimpregnated methyl methacrylate beads (Septopal). Clin Orthop Relat Res 1993; (295): 43-46.
13. Birkeland Ø, Espehaug B, Havelin LI, Furnes O. Bone cement product and failure in total knee arthroplasty. Acta Orthop 2017; 88 (1): 75-81.
14. Konrad-Martin D, James KE, Gordon JS, Reavis KM, Phillips DS et al. Evaluation of audiometric threshold shift criteria for ototoxicity monitoring. J Am Acad Audiol 2010; 21 (5): 301- 314.
15. Aladağ I, Güven M, Songu M. Prevention of gentamicin ototoxicity with N-acetylcysteine and vitamin A. J Laryngol Otol 2016; 130 (5): 440-446.
16. Turnidge JD, Waterston JA. Gentamicin and ototoxicity: why this drug is still in use. Med J Aust 2012; 196 (11): 665-666.
17. Saleh P, Abbasalizadeh S, Rezaeian S, Naghavi-Behzad M, Piri R, Pourfeizi HH. Gentamicin-mediated ototoxicity and nephrotoxicity: a clinical trial study. Niger Med J 2016; 57 (6): 347-352.
18. Behnoud F, Davoudpur K, Goodarzi MT. Can aspirin protect or at least attenuate gentamicin ototoxicity in humans? Saudi Med J 2009; 30 (9): 1165-1169.
19. Gatell JM, Ferran F, Araujo V, Bonet M, Soriano E, Traserra J et al. Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob Agents Chemother 1987; 31 (9): 1383-1387.
20. Rao SC, Srinivasjois R, Moon K. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 2016; 12: CD005091.
21. Ahmed RM, Hannigan IP, MacDougall HG, Chan RC, Halmagyi GM. Gentamicin ototoxicity: a 23-year selected case series of 103 patients. Med J Aust 2012; 196 (11): 701-704.
22. Walenkamp GH, Vree TB, van Rens TJ. Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res 1986; (205): 171-183.
23. Heidemüller B. Ototoxicity of locally administered aminoglycoside antibiotics. Laryngorhinootologie 1994; 73 (6): 331-337 (in German with abstract in English).
24. Downes S, Brown AE, Mukherjee S. The clearance of gentamicin from antibiotic-loaded bone cement. Int Orthop 1985; 9 (3): 205-207.